Cargando…

Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys

BACKGROUND: High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough ≥2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Claassens, M. M., van Schalkwyk, C., Floyd, S., Ayles, H., Beyers, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336223/
https://www.ncbi.nlm.nih.gov/pubmed/28257424
http://dx.doi.org/10.1371/journal.pone.0172881
_version_ 1782512178034638848
author Claassens, M. M.
van Schalkwyk, C.
Floyd, S.
Ayles, H.
Beyers, N.
author_facet Claassens, M. M.
van Schalkwyk, C.
Floyd, S.
Ayles, H.
Beyers, N.
author_sort Claassens, M. M.
collection PubMed
description BACKGROUND: High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough ≥2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of screening while achieving a specificity of ≥85%. METHODS: We used 2010 Zambia South Africa Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) survey data: a South African (SA) training dataset, a SA testing dataset for internal validation and a Zambian dataset for external validation. Regression analyses investigated relationships between symptoms or combinations of symptoms and active disease. Sensitivity and specificity were calculated for candidate rules. RESULTS: Among all participants, the sensitivity of using only cough ≥2 weeks as a screening rule was less than 25% in both SA and Zambia. The addition of any three of six TB symptoms (cough <2 weeks, night sweats, weight loss, fever, chest pain, shortness of breath), or 2 or more of cough <2 weeks, night sweats, and weight loss, increased the sensitivity to ~38%, while reducing specificity from ~95% to ~85% in SA and ~97% to ~92% in Zambia. Among HIV-negative adults, findings were similar in SA, whereas in Zambia the increase in sensitivity was relatively small (15% to 22%). CONCLUSION: High TB burden countries should investigate cost-effective strategies for systematic screening: one such strategy could be to use our rule in addition to cough ≥2 weeks.
format Online
Article
Text
id pubmed-5336223
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53362232017-03-10 Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys Claassens, M. M. van Schalkwyk, C. Floyd, S. Ayles, H. Beyers, N. PLoS One Research Article BACKGROUND: High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough ≥2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of screening while achieving a specificity of ≥85%. METHODS: We used 2010 Zambia South Africa Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) survey data: a South African (SA) training dataset, a SA testing dataset for internal validation and a Zambian dataset for external validation. Regression analyses investigated relationships between symptoms or combinations of symptoms and active disease. Sensitivity and specificity were calculated for candidate rules. RESULTS: Among all participants, the sensitivity of using only cough ≥2 weeks as a screening rule was less than 25% in both SA and Zambia. The addition of any three of six TB symptoms (cough <2 weeks, night sweats, weight loss, fever, chest pain, shortness of breath), or 2 or more of cough <2 weeks, night sweats, and weight loss, increased the sensitivity to ~38%, while reducing specificity from ~95% to ~85% in SA and ~97% to ~92% in Zambia. Among HIV-negative adults, findings were similar in SA, whereas in Zambia the increase in sensitivity was relatively small (15% to 22%). CONCLUSION: High TB burden countries should investigate cost-effective strategies for systematic screening: one such strategy could be to use our rule in addition to cough ≥2 weeks. Public Library of Science 2017-03-03 /pmc/articles/PMC5336223/ /pubmed/28257424 http://dx.doi.org/10.1371/journal.pone.0172881 Text en © 2017 Claassens et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Claassens, M. M.
van Schalkwyk, C.
Floyd, S.
Ayles, H.
Beyers, N.
Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys
title Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys
title_full Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys
title_fullStr Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys
title_full_unstemmed Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys
title_short Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys
title_sort symptom screening rules to identify active pulmonary tuberculosis: findings from the zambian south african tuberculosis and hiv/aids reduction (zamstar) trial prevalence surveys
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336223/
https://www.ncbi.nlm.nih.gov/pubmed/28257424
http://dx.doi.org/10.1371/journal.pone.0172881
work_keys_str_mv AT claassensmm symptomscreeningrulestoidentifyactivepulmonarytuberculosisfindingsfromthezambiansouthafricantuberculosisandhivaidsreductionzamstartrialprevalencesurveys
AT vanschalkwykc symptomscreeningrulestoidentifyactivepulmonarytuberculosisfindingsfromthezambiansouthafricantuberculosisandhivaidsreductionzamstartrialprevalencesurveys
AT floyds symptomscreeningrulestoidentifyactivepulmonarytuberculosisfindingsfromthezambiansouthafricantuberculosisandhivaidsreductionzamstartrialprevalencesurveys
AT aylesh symptomscreeningrulestoidentifyactivepulmonarytuberculosisfindingsfromthezambiansouthafricantuberculosisandhivaidsreductionzamstartrialprevalencesurveys
AT beyersn symptomscreeningrulestoidentifyactivepulmonarytuberculosisfindingsfromthezambiansouthafricantuberculosisandhivaidsreductionzamstartrialprevalencesurveys